Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial
- Resource Type
- Article
- Authors
- Yang, Yunpeng; Zhou, Jianya; Zhou, Jianying; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Mao, Li; Selvaggi, Giovanni; Yuan, Xiaobin; Fu, Yuanqing; Wang, Tao; Xiao, Shanshan; Zhang, Li
- Source
- In The Lancet Respiratory Medicine January 2020 8(1):45-53
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600